Global Polysaccharide Hemostatic Agents Market Research Report 2023

Publication ID:

PB504243596

Publication Date:

May 4, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

It is indicated for use in surgical procedures, including cardiac, vascular, orthopedic, spinal, neurological, gynecological, ENT and trauma surgery as an adjunct hemostat when control of bleeding from capillary, venous, or arteriolar vessels by pressure, ligature, and other conventional means is either ineffective or impractical.
Highlights
The global Polysaccharide Hemostatic Agents market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Polysaccharide Hemostatic Agents is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Polysaccharide Hemostatic Agents is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Polysaccharide Hemostatic Agents include Starch Medical, EndoClot, CryoLife Inc., Saikesaisi Holding Group and Guizhou Jinjiu Biotech, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Polysaccharide Hemostatic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polysaccharide Hemostatic Agents.
The Polysaccharide Hemostatic Agents market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Polysaccharide Hemostatic Agents market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polysaccharide Hemostatic Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Starch Medical
EndoClot
CryoLife Inc.
Saikesaisi Holding Group
Guizhou Jinjiu Biotech
Segment by Type
1g
3g
5g
Segment by Application
Hospital
Specialist Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Polysaccharide Hemostatic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Polysaccharide Hemostatic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Polysaccharide Hemostatic Agents Market Overview
1.1 Product Overview and Scope of Polysaccharide Hemostatic Agents
1.2 Polysaccharide Hemostatic Agents Segment by Type
1.2.1 Global Polysaccharide Hemostatic Agents Market Value Comparison by Type (2023-2029)
1.2.2 1g
1.2.3 3g
1.2.4 5g
1.3 Polysaccharide Hemostatic Agents Segment by Application
1.3.1 Global Polysaccharide Hemostatic Agents Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Other
1.4 Global Polysaccharide Hemostatic Agents Market Size Estimates and Forecasts
1.4.1 Global Polysaccharide Hemostatic Agents Revenue 2018-2029
1.4.2 Global Polysaccharide Hemostatic Agents Sales 2018-2029
1.4.3 Global Polysaccharide Hemostatic Agents Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Polysaccharide Hemostatic Agents Market Competition by Manufacturers
2.1 Global Polysaccharide Hemostatic Agents Sales Market Share by Manufacturers (2018-2023)
2.2 Global Polysaccharide Hemostatic Agents Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Polysaccharide Hemostatic Agents Average Price by Manufacturers (2018-2023)
2.4 Global Polysaccharide Hemostatic Agents Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Polysaccharide Hemostatic Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Polysaccharide Hemostatic Agents, Product Type & Application
2.7 Polysaccharide Hemostatic Agents Market Competitive Situation and Trends
2.7.1 Polysaccharide Hemostatic Agents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Polysaccharide Hemostatic Agents Players Market Share by Revenue
2.7.3 Global Polysaccharide Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Polysaccharide Hemostatic Agents Retrospective Market Scenario by Region
3.1 Global Polysaccharide Hemostatic Agents Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Polysaccharide Hemostatic Agents Global Polysaccharide Hemostatic Agents Sales by Region: 2018-2029
3.2.1 Global Polysaccharide Hemostatic Agents Sales by Region: 2018-2023
3.2.2 Global Polysaccharide Hemostatic Agents Sales by Region: 2024-2029
3.3 Global Polysaccharide Hemostatic Agents Global Polysaccharide Hemostatic Agents Revenue by Region: 2018-2029
3.3.1 Global Polysaccharide Hemostatic Agents Revenue by Region: 2018-2023
3.3.2 Global Polysaccharide Hemostatic Agents Revenue by Region: 2024-2029
3.4 North America Polysaccharide Hemostatic Agents Market Facts & Figures by Country
3.4.1 North America Polysaccharide Hemostatic Agents Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Polysaccharide Hemostatic Agents Sales by Country (2018-2029)
3.4.3 North America Polysaccharide Hemostatic Agents Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Polysaccharide Hemostatic Agents Market Facts & Figures by Country
3.5.1 Europe Polysaccharide Hemostatic Agents Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Polysaccharide Hemostatic Agents Sales by Country (2018-2029)
3.5.3 Europe Polysaccharide Hemostatic Agents Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Polysaccharide Hemostatic Agents Market Facts & Figures by Country
3.6.1 Asia Pacific Polysaccharide Hemostatic Agents Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Polysaccharide Hemostatic Agents Sales by Country (2018-2029)
3.6.3 Asia Pacific Polysaccharide Hemostatic Agents Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Polysaccharide Hemostatic Agents Market Facts & Figures by Country
3.7.1 Latin America Polysaccharide Hemostatic Agents Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Polysaccharide Hemostatic Agents Sales by Country (2018-2029)
3.7.3 Latin America Polysaccharide Hemostatic Agents Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Polysaccharide Hemostatic Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Polysaccharide Hemostatic Agents Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Polysaccharide Hemostatic Agents Sales by Country (2018-2029)
3.8.3 Middle East and Africa Polysaccharide Hemostatic Agents Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Polysaccharide Hemostatic Agents Sales by Type (2018-2029)
4.1.1 Global Polysaccharide Hemostatic Agents Sales by Type (2018-2023)
4.1.2 Global Polysaccharide Hemostatic Agents Sales by Type (2024-2029)
4.1.3 Global Polysaccharide Hemostatic Agents Sales Market Share by Type (2018-2029)
4.2 Global Polysaccharide Hemostatic Agents Revenue by Type (2018-2029)
4.2.1 Global Polysaccharide Hemostatic Agents Revenue by Type (2018-2023)
4.2.2 Global Polysaccharide Hemostatic Agents Revenue by Type (2024-2029)
4.2.3 Global Polysaccharide Hemostatic Agents Revenue Market Share by Type (2018-2029)
4.3 Global Polysaccharide Hemostatic Agents Price by Type (2018-2029)
5 Segment by Application
5.1 Global Polysaccharide Hemostatic Agents Sales by Application (2018-2029)
5.1.1 Global Polysaccharide Hemostatic Agents Sales by Application (2018-2023)
5.1.2 Global Polysaccharide Hemostatic Agents Sales by Application (2024-2029)
5.1.3 Global Polysaccharide Hemostatic Agents Sales Market Share by Application (2018-2029)
5.2 Global Polysaccharide Hemostatic Agents Revenue by Application (2018-2029)
5.2.1 Global Polysaccharide Hemostatic Agents Revenue by Application (2018-2023)
5.2.2 Global Polysaccharide Hemostatic Agents Revenue by Application (2024-2029)
5.2.3 Global Polysaccharide Hemostatic Agents Revenue Market Share by Application (2018-2029)
5.3 Global Polysaccharide Hemostatic Agents Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Starch Medical
6.1.1 Starch Medical Corporation Information
6.1.2 Starch Medical Description and Business Overview
6.1.3 Starch Medical Polysaccharide Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Starch Medical Polysaccharide Hemostatic Agents Product Portfolio
6.1.5 Starch Medical Recent Developments/Updates
6.2 EndoClot
6.2.1 EndoClot Corporation Information
6.2.2 EndoClot Description and Business Overview
6.2.3 EndoClot Polysaccharide Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.2.4 EndoClot Polysaccharide Hemostatic Agents Product Portfolio
6.2.5 EndoClot Recent Developments/Updates
6.3 CryoLife Inc.
6.3.1 CryoLife Inc. Corporation Information
6.3.2 CryoLife Inc. Description and Business Overview
6.3.3 CryoLife Inc. Polysaccharide Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.3.4 CryoLife Inc. Polysaccharide Hemostatic Agents Product Portfolio
6.3.5 CryoLife Inc. Recent Developments/Updates
6.4 Saikesaisi Holding Group
6.4.1 Saikesaisi Holding Group Corporation Information
6.4.2 Saikesaisi Holding Group Description and Business Overview
6.4.3 Saikesaisi Holding Group Polysaccharide Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Saikesaisi Holding Group Polysaccharide Hemostatic Agents Product Portfolio
6.4.5 Saikesaisi Holding Group Recent Developments/Updates
6.5 Guizhou Jinjiu Biotech
6.5.1 Guizhou Jinjiu Biotech Corporation Information
6.5.2 Guizhou Jinjiu Biotech Description and Business Overview
6.5.3 Guizhou Jinjiu Biotech Polysaccharide Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Guizhou Jinjiu Biotech Polysaccharide Hemostatic Agents Product Portfolio
6.5.5 Guizhou Jinjiu Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Polysaccharide Hemostatic Agents Industry Chain Analysis
7.2 Polysaccharide Hemostatic Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Polysaccharide Hemostatic Agents Production Mode & Process
7.4 Polysaccharide Hemostatic Agents Sales and Marketing
7.4.1 Polysaccharide Hemostatic Agents Sales Channels
7.4.2 Polysaccharide Hemostatic Agents Distributors
7.5 Polysaccharide Hemostatic Agents Customers
8 Polysaccharide Hemostatic Agents Market Dynamics
8.1 Polysaccharide Hemostatic Agents Industry Trends
8.2 Polysaccharide Hemostatic Agents Market Drivers
8.3 Polysaccharide Hemostatic Agents Market Challenges
8.4 Polysaccharide Hemostatic Agents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Starch Medical
EndoClot
CryoLife Inc.
Saikesaisi Holding Group
Guizhou Jinjiu Biotech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂